In Episode 145, Fred Chong returns to discuss what's new at Infleqtion, now a public company, and the work that's keeping him busy across both academia and industry. The team dig into Quantum for Bio, a multimodal cancer biomarker discovery project developed with Welcome Leap and now continuing with IBM, where hybrid quantum-classical algorithms are uncovering relationships between genes, RNA, and tumor imaging that classical methods haven't been able to tackle. Fred shares Peter Shor's persp...
